Brief: Avenue Therapeutics Says Delivered To Invagen Pharmaceuticals Notice Of Termination Of Stock Purchase & Merger Agreement
04/11/2021 22:27
Nov 4 (Reuters) - Avenue Therapeutics Inc ATXI.O :
* AVENUE THERAPEUTICS - ON NOV 1 DELIVERED TO INVAGEN
PHARMACEUTICALS NOTICE OF TERMINATION OF STOCK PURCHASE & MERGER
AGREEMENT DATED AS OF NOV 12, 2018
* AVENUE THERAPEUTICS - INVAGEN OWNS ABOUT 35%, OR 5.8
MILLION
COMMON SHARES, OF CO'S ISSUED AND OUTSTANDING COMMON STOCK
Source text for Eikon: ID:
Further company coverage: ATXI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Avenue Therapeutics
See all newsBrief: Axsome Therapeutics Acquires AZD7325, A Selective GABA-A Modulator For Treatment Of Epilepsy
Avenue Therapeutics Inc expected to post a loss of 57 cents a share - Earnings Preview
Brief: Avenue Therapeutics Annji Intends To Terminate License Agreement With Co
Brief: Avenue Therapeutics Receives Delist Letter From Nasdaq Under Nasdaq Listing Rule 5550(B)(1)
Avenue Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary